Focused HCP discussion and proactive education on relapse identification and management improves patient reporting and timely treatment of MS relapse

CMSC Annual Meeting, 2017

Authors: R.W. Waltrip II, N. Mahler, A. Ahsan, and L.B. Herbert

Partnering with Mallinckrodt Pharmaceuticals, this abstract was published at the CMSC Annual Meeting, showcasing data from Health Union’s Multiple Sclerosis In America 2017, a syndicated research study.